Menu

CME Corner

Active Programs

Dialogue with the Experts: Diagnosing, Assessing, and Managing Inflammatory Rheumatic Diseases

Inflammatory rheumatic diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), have a significant negative impact on patients’ physical functioning and quality of life. This activity will examine early recognition and guideline-driven treatment for these conditions. ...

  • Video Roundtable Video Roundtable
  • ACCME

Psoriatic Arthritis: Understanding the Patient Experience to Improve Patient Satisfaction and Outcomes

The validated tools to assess PsA severity often do not capture what patients consider to be most important/challenging about their disease. To effectively engage patients when developing treatment plans, clinicians need information about the patients’ individual experiences with, perceptions of, and beliefs about PsA. In this “Rate the Quality” activity, you will meet three patients and rate the ...

  • Mobile + Online on RealCME
  • ACCME

Expired Programs

Assessing Psoriatic Arthritis Severity, Setting Goals, and Monitoring Progress

Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. An estimated 7.5 million Americans have psoriasis, and an estimated 30% to 40% of individuals with psoriasis also develop PsA. Symptoms of PsA include fatigue, pain and inflammation in joints, and potentially progressive joint damage. Despite the availability of a variety of treatment options, many patients wi ...

  • Online Presentation Online Presentation
  • ACCME

Diagnosis of PsA: Achieving an Accurate Assessment

Approximately 30% to 40% of people with psoriasis will also develop psoriatic arthritis (PsA), a painful and potentially disfiguring condition that remains underdiagnosed. Symptoms include fatigue, joint inflammation, and potentially progressive joint damage. This activity will examine the considerations for assessment and diagnosis of PsA. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Improving Patient Satisfaction with Psoriatic Arthritis Treatment

An estimated 7.5 million Americans have psoriasis, and an estimated 30% to 40% of individuals with psoriasis also develop psoriatic arthritis (PsA). Despite the availability of a variety of treatment options, many patients with PsA continue to experience suboptimal outcomes. This activity will examine tailoring therapy to maximize patient satisfaction. ...

  • Online Presentation Online Presentation
  • ACCME

Integrating Recently Approved Therapies into Psoriatic Arthritis Treatment Plans

Despite the availability of a variety of treatment options, many patients with psoriatic arthritis (PsA) continue to experience suboptimal outcomes. Recent research, however, has resulted in several newly approved and investigational agents that are likely to improve patient outcomes. This activity will examine recently approved and investigational therapies and their potential integration into tr ...

  • Online Presentation Online Presentation
  • ACCME

Management of Psoriatic Disease: Care and Ongoing Monitoring

Psoriatic arthritis (PsA) is underdiagnosed and undermanaged in the United States, and comorbidities that are often associated with PsA are sometimes overlooked. Many patients with PsA experience a significant emotional and physical impact from this condition despite an increase in options for successful treatment. This activity will examine the importance of early recognition and the consideratio ...

  • Mobile + Online on QuantiaMD
  • ACCME
Main Menu
EDITOR'S PICKS